Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Viscosupplementationindustry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Modality trends
2.6 End-use trends
Chapter 3 Viscosupplementation Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population prone to osteoarthritis
3.2.1.2 Rising demand for minimally invasive treatments
3.2.1.3 New product launches
3.2.1.4 Increasing preference for single injection treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of hyaluronic acid treatment
3.2.2.2 Presence of alternatives for knee osteoarthritis treatment
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By source of origin
3.3.4 By end use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Strategy dashboard
Chapter 5 Viscosupplementation Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Single Injection
5.3 3 Injections
5.4 5 Injections
Chapter 6 Viscosupplementation Market Size and Forecast, By Source of Origin (USD Million)
6.1 Key trends, by source of origin
6.2 Avian Origin
6.3 Non-avian Origin
Chapter 7 Viscosupplementation Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Others
Chapter 8 Viscosupplementation Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Sweden
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Thailand
8.4.7 Indonesia
8.4.8 Philippines
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Columbia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Turkey
8.6.6 Iran
Chapter 9 Company Profiles
9.1 Anika Therapeutics, Inc.
9.2 Aptissen
9.3 Bioventus
9.4 Chugai Pharmaceutical Co., Ltd
9.5 Croma-Pharma GmbH
9.6 Dr. Reddy’s Laboratories Ltd.
9.7 Ferring B.V.
9.8 Fidia Pharma USA Inc.
9.9 Johnson & Johnson Services, Inc.
9.10 LSP Bio Ltd
9.11 Mediteck BeOnTop
9.12 Mylan Inc.
9.13 OrthogenRX
9.14 Genzyme Corporation
9.15 SEIKAGAKU CORPORATION
9.16 Stellar Pharmaceuticals Inc.
9.17 Tecnofarma SA
9.18 TRB Chemedica International SA
9.19 Wellchem Pharmaceuticals Pte Ltd.
9.20 Zimmer Biomet
